EMA-Backed Pediatric Research Network To Initiate Discussions On 'Unfeasible' Trials
This article was originally published in SRA
Executive Summary
The European Network of Paediatric Research at the European Medicines Agency (Enpr-EMA) is looking at how it can gather and share information with drug companies and regulators on clinical trials that sponsors have been asked to conduct under the EU Paediatric Regulation but which may no longer be feasible1.